Brief: Median Technologies FY Revenue Up At EUR 20.5 Million

Median Technologies SA

21/04/2022 18:27

April 21 (Reuters) - Median Technologies SA  ALMDT.PA :
    * FY REVENUE ROSE 52.4 PERCENT TO 20.5 MILLION EUR
    * RECORD HIGH REVENUE OF EUR 5.7 MILLION IN Q1 2022, UP 9.2%
COMPARED WITH Q1 2021
    * FURTHER GROWTH IN ORDER BACKLOG TO EUR 62.3 MILLION AS OF
MARCH
31, 2022, UP 18.4% COMPARED WITH MARCH 31, 2021
    * Q1 PRESS RELEASE ON OUTSTANDING DETECTION/CHARACTERIZATION
PERFORMANCES FOR IBIOPSY LUNG CANCER SCREENING CADE/CADX
SOFTWARE AS MEDICAL DEVICE (SAMD) AND START OF DISCUSSIONS WITH
FDA
    * REVENUE OF EUR 20.5 MILLION AS OF DECEMBER 31, 2021, UP
52.4%
COMPARED TO DECEMBER 31, 2020
    * CASH AND CASH EQUIVALENTS OF EUR 33.1 MILLION AS OF MARCH
31,
2022
    * END-MARCH 2022 MEDIAN'S Q1 REVENUE EUR 5.7 MILLION, UP
9.2%
RELATIVE TO REVENUE IN YEAR-EARLIER PERIOD
    * ORDER BACKLOG STOOD AT EUR 62.3 MILLION ON MARCH 31, 2022,
UP
18.4% RELATIVE TO MARCH 31, 2021 (EUR 52.6 MILLION)
    * EMD-MARCH 2022 CASH AND CASH EQUIVALENTS TOTALED EUR 33.1
MILLION
    * BIOPSY IS ALSO GENERATING MAJOR INTEREST FROM OUR PHARMA
PARTNERS. FIRST REGULATORY EXCHANGES WITH FDA HAVE NOW BEEN
INITIATED AND WE PLAN TO START OUR PIVOTAL TRIALS LATE 2022 -
CEO

Source text for Eikon:  ID:nBw2tldBTa 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))